CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 136 filers reported holding CONSTELLATION PHARMCETICLS I in Q4 2020. The put-call ratio across all filers is 1.58 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,440,000 | -11.2% | 50,000 | -37.5% | 1.27% | -28.0% |
| Q3 2020 | $1,621,000 | -17.0% | 80,000 | +23.1% | 1.76% | -20.1% |
| Q2 2020 | $1,953,000 | -40.8% | 65,000 | -38.1% | 2.21% | -50.3% |
| Q1 2020 | $3,300,000 | -36.3% | 105,000 | -4.5% | 4.44% | -19.6% |
| Q4 2019 | $5,182,000 | +401.2% | 110,000 | -31.2% | 5.52% | +328.3% |
| Q3 2019 | $1,034,000 | -29.9% | 160,000 | +33.3% | 1.29% | -19.1% |
| Q2 2019 | $1,474,000 | – | 120,000 | – | 1.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP, LLC | 3,034,083 | $41,112,000 | 40.71% |
| Svennilson Peter | 4,677,939 | $63,386,000 | 33.76% |
| VHCP Management II, LLC | 726,677 | $9,846,000 | 2.88% |
| Casdin Capital, LLC | 1,556,999 | $21,097,000 | 2.32% |
| Cormorant Asset Management, LP | 1,271,687 | $17,231,000 | 1.16% |
| VHCP Management III, LLC | 66,667 | $903,000 | 0.53% |
| Hillhouse Capital Management | 317,921 | $4,308,000 | 0.18% |
| Orbimed Advisors | 835,842 | $11,326,000 | 0.18% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 66,186 | $897,000 | 0.13% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 253,400 | $3,434,000 | 0.13% |